You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Moderna
since
auto-detected in 36 stories
9 days ago
The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns.
FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal ⊖
The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for the upcoming influenza season.
Trump administration reverses move to block Moderna flu vaccine trial ⊖
U-turn comes after backlash from the company and US biotech industry
U.S. FDA reverses course, will review Moderna's modified flu vaccine application ○
Moderna said on Wednesday the U.S. Food and Drug Administration has agreed to review its influenza vaccine application, reversing an earlier decision.
14 days ago
Stocks making the biggest moves midday: Moderna, Instacart, Rivian Automotive, DraftKings, Coinbase & more ○
found
Here are some of the biggest movers in midday trading.
16 days ago
US FDA declines Moderna flu vaccine review amid vaccine guidance rollback ⊖
found
a story from Al Jazeera 🚨 › Al Jazeera English
CEO Stephane Bancel said the letter refusing review did not cite 'any safety or efficacy concerns'.
Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more ○
found
These are the stocks posting the largest moves in midday trading.
Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more ○
These are the stocks posting the largest moves in early trading.
Moderna says FDA refuses to review its application for experimental flu shot ⊖
Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called mRNA-1010.
51 days ago
Moderna just had its best day since October. Here's what's going on, and what analysts expect ⊕
Analysts pointed to an upcoming health care conference and cancer data study release as potential catalysts for Moderna's ongoing rally.